bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.910
-0.020 (-1.04%)
At close: Oct 11, 2024, 4:00 PM
1.880
-0.030 (-1.57%)
After-hours: Oct 11, 2024, 4:34 PM EDT
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $25.77 million as of October 11, 2024. Its market cap has increased by 138.58% in one year.
Market Cap
25.77M
Enterprise Value
26.35M
1-Year Change
138.58%
Ranking
Category
Stock Price
$1.91
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $44.99M to $25.77M, a decrease of -42.73%. That is a compound annual growth rate of -23.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 11, 2024 | 25.70M | 83.57% |
| Dec 29, 2023 | 14.00M | 4.48% |
| Dec 30, 2022 | 13.40M | -70.22% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Precision Optics Corporation | 27.24M |
| Flora Growth | 27.09M |
| MiNK Therapeutics | 26.53M |
| T2 Biosystems | 25.87M |
| Tempest Therapeutics | 25.84M |
| Longeveron | 25.70M |
| IRIDEX | 25.62M |
| Inspira Technologies Oxy B.H.N. | 25.35M |